Ledger.Open graph →
SEC Form D · Amendment · filed December 23, 2020

General Oncology, Inc

Offering
$2.5M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Gregg Goldstein · Newton, MAExec · DirectorJeffrey A. Glazier · Newton, MAExecArnold Glazier · Newton, MAExec · DirectorMichael D. Sigman · Newton, MADirectorMichael J. Petit · Newton, MADirectorRegina M. Ali · Waltham, MAExec · DirectorRafe Petty · Denver, COExecMichael Landau · New York, NYExec · Directornull Alif Capital Management · San Francisco, CAExecMaria M. Falkinhoff · New York, NYExec · DirectorJeronimo A. Bremer · Lomas de Chapultepec, Mex.D.F., O5Exec · DirectorMichael D. Sigman · Newton, MADirectorMichael J. Petit · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗